A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours

Clinical trial NCT06170190 · COMPLETED

Trial details

NCT number: NCT06170190
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Unresectable or Metastatic Solid Tumors

Start date: 2024-01-16
Primary completion: 2025-02-19
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.